Teladoc Health Inc (TDOC) financials
Teladoc Health revenue and earnings by year
Teladoc Health's revenue was $2.53 billion in the fiscal year to December 31, 2025, down 1.5% from the year before. Net income was -$200 million, -7.9% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 39.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.5 | 2.6 | 2.6 | 2.4 | 2.0 | 1.1 | 0.6 | 0.4 | 0.2 | 0.1 |
| Revenue growth | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | 97.7% | 32.4% | 79.1% | 89.4% | — |
| Gross profit | 1.8 | 1.8 | 1.8 | 1.7 | 1.4 | 0.7 | 0.4 | 0.3 | 0.2 | 0.1 |
| Gross margin | 69.5% | 70.8% | 70.8% | 69.1% | 68.0% | 64.3% | 66.7% | 69.2% | 73.6% | 74.0% |
| Operating income | -0.3 | -1.0 | -0.2 | -13.7 | -0.3 | -0.5 | -0.1 | -0.1 | -0.1 | -0.1 |
| Operating margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -18.3% | -32.3% | -50.9% |
| Net income | -0.2 | -1.0 | -0.2 | -13.7 | -0.4 | -0.5 | -0.1 | -0.1 | -0.1 | -0.1 |
| Net margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.3% | -17.9% | -23.2% | -45.8% | -60.3% |
| Diluted EPS | -$1.14 | -$5.87 | -$1.34 | -$84.60 | -$2.73 | -$5.36 | -$1.39 | -$1.48 | -$1.91 | -$1.72 |
| Free cash flow | 0.2 | 0.2 | 0.2 | 0.0 | 0.1 | -0.1 | 0.0 | -0.0 | -0.0 | -0.1 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open TDOC in Markets.
How Teladoc Health makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Teladoc Health Integrated Care | $398M | 65.9% |
| Better Help | $207M | 34.1% |
See also: TDOC returns
No forecast, no recommendation. This page describes Teladoc Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.